Channelopathies Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
CRBP | C | Corbus Pharmaceuticals Holdings, Inc. | -1.71 | |
TVTX | F | Travere Therapeutics, Inc. | -4.55 |
Related Industries: Biotechnology Drug Manufacturers - Major
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
BBP | D | BioShares Biotechnology Products Fund | 1.41 | |
XBI | D | SPDR S&P Biotech ETF | 0.43 | |
LABD | D | Direxion Daily S&P Biotech Bear 3X Shares | 0.33 | |
SBIO | D | ALPS Medical Breakthroughs ETF | 0.32 | |
LABU | D | Direxion Daily S&P Biotech Bull 3X Shares | 0.28 |
Compare ETFs
- Channelopathies
Channelopathies are diseases caused by disturbed function of ion channel subunits or the proteins that regulate them. These diseases may be either congenital (often resulting from a mutation or mutations in the encoding genes) or acquired (often resulting from autoimmune attack on an ion channel).
There are a large number of distinct dysfunctions known to be caused by ion channel mutations. The genes for the construction of ion channels are highly conserved amongst mammals and one condition, hyperkalemic periodic paralysis, was first identified in the descendants of Impressive, a registered Quarter Horse.
The channelopathies of human skeletal muscle include hyper- and hypokalemic (high and low potassium blood concentrations) periodic paralysis, myotonia congenita and paramyotonia congenita.
Channelopathies affecting synaptic function are a type of synaptopathy.
Popular Now
Recent Comments
- TraderMike on IZM
- SuccessfulGerbil321 on IZM
- TraderMike on IZM
- TraderMike on Today's Outage
- Crunching_The_Market on Today's Outage
From the Blog
Featured Articles